Health & Fitness

Medieval medicine is undergoing a reputation makeover. New research reveals that far from being stuck in superstition, early Europeans actively explored healing practices based on nature, observation, and practical experience—some of which uncannily echo today’s wellness trends on TikTok.

from Top Health News -- ScienceDaily https://ift.tt/P8R0cfi

Stroke kills millions, but Osaka researchers have unveiled GAI-17, a drug that halts toxic GAPDH clumping, slashes brain damage and paralysis in mice—even when given six hours post-stroke—and shows no major side effects, hinting at a single therapy that could also tackle Alzheimer’s and other tough neurological disorders.

from Top Health News -- ScienceDaily https://ift.tt/YlCZ0q4

Obesity-related cancer deaths in the U.S. have tripled in just two decades, with women, older adults, and minority groups most affected. New research presented at ENDO 2025 highlights how obesity—linked to 13 different cancers—is now a major contributor to cancer mortality, especially in underserved and rural populations. Despite the growing awareness of obesity’s broader health impacts, this surge in cancer fatalities reveals an urgent need for targeted public health interventions and equitable access to care.

from Top Health News -- ScienceDaily https://ift.tt/gDIiNXL

Kids who consume artificial and natural sweeteners like aspartame, sucralose, and glycyrrhizin may face an increased risk of early puberty, especially if they carry specific genetic markers. This large-scale Taiwanese study links sweeteners to hormonal changes and gut bacteria imbalances that can speed up puberty, with effects differing between boys and girls. Early onset puberty has been tied to serious health consequences later in life, including emotional stress and metabolic disorders. The findings could reshape dietary recommendations and encourage genetic screening to mitigate long-term risks.

from Top Health News -- ScienceDaily https://ift.tt/KJahxkD

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual treatment led to significantly greater weight loss than tirzepatide alone. Women using both treatments lost 17% of their body weight on average, compared to 14% in those not using hormone therapy—and nearly half achieved dramatic 20%+ weight loss.

from Top Health News -- ScienceDaily https://ift.tt/OX3KTSY

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed breast cancer tumor growth. The research, presented at ENDO 2025, links body fat reduction to better cancer outcomes, suggesting that these next-generation weight-loss drugs might offer unexpected benefits beyond metabolic health. With traditional dieting often falling short, this dual-action approach could reshape how doctors tackle obesity-related cancers.

from Top Health News -- ScienceDaily https://ift.tt/UVgL0xR

For centuries, we’ve imagined Neanderthals as distant cousins — a separate species that vanished long ago. But thanks to AI-powered genetic research, scientists have revealed a far more entangled history. Modern humans and Neanderthals didn’t just cross paths; they repeatedly interbred, shared genes, and even merged populations over nearly 250,000 years. These revelations suggest that Neanderthals never truly disappeared — they were absorbed. Their legacy lives on in our DNA, reshaping our understanding of what it means to be human.

from Top Health News -- ScienceDaily https://ift.tt/3yM785R